Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial
Andrew R. Clamp, Jonathan A. Ledermann(Cancer Institute (WIA)), Dolores Gallardo‐Rincón(Instituto Nacional de Cancerología), Christine Parkinson(Cambridge University Hospitals NHS Foundation Trust), Babasola O Popoola(MRC Clinical Trials Unit at UCL), Rosemary Lord(Clatterbridge Cancer Centre NHS Foundation Trust), Mahesh Parmar(University College London), Adrian Cook(University College London), Marcia Hall(Hillingdon Hospitals NHS Foundation Trust), Timothy Perren(Royal Marsden NHS Foundation Trust), Sarah Williams(Birmingham City Hospital), Francesca Schiavone(MRC Clinical Trials Unit at UCL), Rosalind Glasspool(Institut Bergonié), Sharadah Essapen(Royal Surrey County Hospital), Helena Nam(Southend University Hospital NHS Foundation Trust), James D. Brenton(University of Cambridge), Lucy McAvan(University Hospital Coventry), Andrew Dean, Richard Kaplan(University College London), Sudha Sundar(Sandwell & West Birmingham Hospitals NHS Trust), Susana Banerjee(Royal Marsden NHS Foundation Trust), Sarah P. Blagden(Churchill Hospital), Elizabeth C James(MRC Clinical Trials Unit at UCL), Ann Marie Swart(University of East Anglia), Fuad Fananapazir(MRC Clinical Trials Unit at UCL), Jonathan Badrock(MRC Clinical Trials Unit at UCL), Iain A. McNeish(Beatson West of Scotland Cancer Centre), G. Dark(Freeman Hospital), Jae-Won Kim(Seoul National University), C.L. Hanna(Velindre Cancer Centre), Dearbhaile M. O’Donnell, Kate Scatchard(Royal Devon and Exeter Hospital)
Cited by 45
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k